PODCAST · news
Biohacking News
by Inception Point Ai
Biohacking News Tracker: Stay Ahead in the World of Biohacking Welcome to "Biohacking News Tracker," your go-to podcast for the latest updates and breakthroughs in the world of biohacking. From cutting-edge technologies and genetic engineering to personalized health and wellness strategies, we cover it all. Each episode features expert interviews, in-depth analysis, and the most current news in biohacking and human optimization. Join us as we explore the intersection of biology and technology, uncovering innovative ways to enhance human potential. Whether you're a biohacking enthusiast, a tech aficionado, or simply curious about the future of health, "Biohacking News Tracker" offers insightful and actionable information. Subscribe now and stay ahead in the rapidly evolving world of biohacking. For more info https://www.quietperiodplease.com/ This show i
Episodes
-
From DIY to Luxury Clinics: Inside the Biohacking Boom and the Backlash
The biohacking industry is in a phase of rapid mainstreaming, with activity in the past week centered on consumer-facing events, longevity-focused services, and a growing pushback against overhyped “quick fixes.”[2][8] Over the last 48 hours, social channels have highlighted a surge of biohacking...
-
The Biohacking Boom: From DIY Experiments to Premium Longevity Clinics Worth Billions
The biohacking industry is in a phase of rapid commercialization and premiumization, with strong growth forecasts and visible shifts toward high-priced, clinic-based “longevity” services supported by consumer demand for performance, aesthetics, and preventative health. According to Globe Market...
-
Biohacking Market Boom: How Peptides, Regulation, and Consumer Demand Are Reshaping Wellness
The biohacking industry today is in a phase of rapid commercial growth, rising regulatory scrutiny, and highly fragmented innovation, with the last week reinforcing these trends rather than overturning them. Social and consumer data show that interest in enhancement style biohacking continues to...
-
Biohacking Goes Mainstream: Peptides, Mitochondria, and the Regulatory Reckoning
The biohacking industry is entering a more mainstream but tightly scrutinized phase, marked by strong consumer demand for performance and longevity products, alongside growing concerns from regulators and physicians about safety and ethics. Over the past week, peptides and mitochondrial support...
-
Biohacking Goes Luxury: Why Premium Gut Health and Peptides Are the New Wellness Frontier
The biohacking industry enters mid June 2026 in a phase of visible commercialization and premiumization, with recent activity centered on longevity, gut health, peptides, and so called frequency tuned and protocol based approaches to self optimization. Over the past 48 hours, one of the clearest...
-
Biohacking Goes Mainstream: Why Longevity Tech is Entering the Medical Clinic
The biohacking industry is in a period of rapid but uneven expansion, with strong consumer enthusiasm for longevity and wellness colliding with rising regulatory scrutiny and economic caution. In the past week, activity has centered around high profile events and investment in experiential…
more -
From Fringe to Mainstream: How Biohacking Became Data-Driven Longevity
The biohacking industry is entering a consolidation and professionalization phase, with longevity and measurable outcomes overtaking novelty hacks as the main drivers of activity. In the past 48 hours, longevity has been pushed as the central narrative for wellness and biohacking brands, tying...
-
From Hype to Science: How Biohacking Became Evidence Based in 2026
The biohacking industry is navigating a week defined by cautious growth, tighter scrutiny, and a visible shift from flashy optimization toward evidence based health and longevity tools. In the past 48 hours, conversation at wellness and longevity events has focused on moving beyond gimmicky hacks...
-
Biohacking 2026: From Gadgets to Science-Based Wellness and Longevity
The biohacking industry over the past 48 hours is operating in a climate of strong demand but growing skepticism, with wellness, longevity, and preventive health continuing to drive both consumer interest and investment. Recent market commentary places the global biohacking market at roughly 32.5...
-
Biohacking Goes Mainstream: How Regulation and Data Are Reshaping Performance Medicine in 2024
The biohacking industry over the past 48 hours is operating in a risk‑on but cautious environment, shaped by capital markets volatility, tightening regulation around longevity drugs and wearables, and an accelerating shift toward at home performance and recovery technologies. On the market side,...
-
Biohacking in 2025: Why Evidence and Regulation Are Replacing Hype
The biohacking industry is currently experiencing steady but cautious growth, with recent activity focused on strategic partnerships, targeted product launches, and closer alignment with regulators rather than explosive new breakthroughs. Over the past week, several biohacking and human…
more -
Biohacking 2024: From Hype to Healthcare Integration and Regulatory Reality
The global biohacking industry is experiencing a complex moment marked by strong consumer interest, rapid commercialization, and intensifying regulatory scrutiny. Over the past 48 hours, sector news has centered less on blockbuster deals and more on how companies are adapting business models,...
-
Biohacking in 2024: From DIY Experiments to Data-Driven Longevity Programs
The biohacking industry is currently in a consolidation and recalibration phase, marked by cautious growth, increasing regulatory attention, and a shift from extreme self-experimentation toward more evidence based longevity and performance solutions. Over the past week, funding activity has…
more -
GLP-1 and Biomarkers: How Biohacking Shifted From Wellness Hype to Real Results
In the past 48 hours, the biohacking industry appears to be driven less by broad consumer wellness hype and more by the commercialization of GLP 1 centered health optimization, continuous biomarker tracking, and low cost virality around weight loss hacks. The clearest signal in the available...
-
Biohacking Goes Mainstream: Wearables, Data, and the Future of Personalized Health
The biohacking industry over the past 48 hours reflects a sector maturing from niche experimentation toward regulated, data driven health optimization. On the market side, wearables and continuous monitoring remain the growth engine. IDC’s latest quarterly wearables tracker, updated this week,...
-
Biohacking 2024: From DIY Experiments to Clinically Validated Health Outcomes
The biohacking industry over the past 48 hours is in a phase of cautious expansion, shaped by tighter regulators, more demanding investors, and consumers shifting from extreme experimentation to measurable health outcomes. On the market side, venture and strategic funding is flowing into…
more -
Biohacking Industry Stable: Influencer Scandals, Supplement Trends, and Smart Ring Innovation in May 2026
In the past 48 hours as of May 5, 2026, the biohacking industry remains stable with no major market movements, deals, partnerships, or regulatory changes reported. Verified data is scarce, showing limited disruptions since May 4. A prominent scandal involves influencer Clvicular, who suffered a...
-
Biohacking Industry Update: Influencer Scandals and Supplement Growth in May 2026
In the past 48 hours, the biohacking industry shows a mix of promotional hype and personal scandals, with no major market movements, deals, partnerships, or regulatory changes reported. Verified data remains scarce, highlighting limited disruptions as of May 4, 2026. A key development is the...
-
Biohacking and Longevity Tech Boom: CGMs, Women's Health, and Consumer Wellness Trends in 2026
In the past 48 hours, the biohacking industry shows steady momentum in longevity tech, with no major market disruptions but growing consumer interest in women's health and non-prescription devices.[1] The overlapping longevity market hit 21.3 billion dollars in 2024 and is projected to reach 63...
-
Biohacking Market Under Fire: Supplement Purity Crisis and Psychedelic Breakthroughs
In the past 48 hours, the biohacking industry shows signs of strain amid a global supplement transparency crisis, with limited major deals or launches but rising scrutiny on product purity. Momentous Vital Aminos, endorsed by podcaster Andrew Huberman, continues gaining traction in emerging…
more -
AI-Powered Fertility Biohacking: How South Korea's Femtech Is Reshaping Couples' Health
In the past 48 hours, the biohacking industry shows steady momentum with niche advancements in wellness tech, though no major market disruptions or verified statistics from the last week emerged. A standout development is a new 20-week sleep study launched April 27 from Dave Asprey's Beyond...
-
Biohacking Industry Crisis: Credibility Collapse and the Future of Longevity Science
In the past 48 hours, the biohacking industry is grappling with a severe credibility crisis sparked by revelations of Peter Attia's ties to Jeffrey Epstein, as detailed in a YouTube video by James Welsh on April 26, 2026, which has amassed over 5,600 views.[1] Attia, once a pillar of the…
more -
Biohacking's Credibility Crisis: What Longevity Industry Faces Now
In the past 48 hours, the biohacking industry faces a major credibility crisis triggered by the fallout from Peter Attia's Epstein connections, spotlighted in a widely viewed YouTube video by James Welsh on April 26, 2026, which has garnered over 5,600 views and dissected Attia's role in...
-
Biohacking Market Surges to 67 Billion by 2035: Take Solutions Leads India Expansion
In the past 48 hours, the biohacking industry shows steady momentum with key expansions and positive market forecasts, though no major disruptions or regulatory shifts emerged. Take Solutions Limited announced on April 17 its entry into India's longevity and anti-aging market via a Regulation 30...
-
Biohacking in 2026: AI Innovation Amid Drug Pricing Pressure and Chinese Competition
In the past 48 hours, the biohacking industry faces headwinds from biotech's broader struggles, with pricing pressures and rising costs compressing drug development returns, as highlighted in a April 22, 2026 podcast by investor David Berry.[1] The Inflation Reduction Act has triggered mandatory...
-
Biohacking 2026: Energy Optimization, Nonna-Maxxing, and Mitochondrial Support Trends
In the past 48 hours, the biohacking industry shows steady momentum driven by 2026 consumer trends toward energy optimization and natural longevity hacks, with no major market disruptions or regulatory shifts reported. Thorne Research leads with its Magnesium Bisglycinate Powder 2026 Lemon-Lime...
-
Biohacking Boom: How FDA Deregulation and GLP-1 Partnerships Are Reshaping Wellness Tech in 2026
Biohacking Industry Current State Analysis Past 48 Hours In the past 48 hours, the biohacking industry shows robust momentum driven by health tech surges and regulatory wins, with Hims and Hers Health stock rocketing 97 percent since late February, reflecting explosive investor confidence in...
-
Peptide Therapy Boom 2026: The Biohacking Mainstream Moment Explained
In the past 48 hours as of April 20, 2026, the biohacking industry shows surging momentum driven by peptide therapies and longevity trends, with no major market disruptions but clear signs of mainstream adoption.[2][5] Peptide therapy searches exploded year-over-year by 281 percent on Google, 459...
-
Biohacking Boom 2026: From Hype to Data-Driven Health Optimization
In the past 48 hours, the biohacking industry shows a surging global boom, particularly in Japan where the movement is exploding as of April 2026, driving demand for devices like the Hatch Restore 2 sleep optimizer[3]. Consumers are increasingly obsessed with personal health tracking via…
more -
Affordable Biohacking 2026: Why Mitolyn and Free Methods Beat Expensive Wellness Gadgets
In the past 48 hours, the biohacking industry shows steady momentum amid rising consumer interest in affordable longevity solutions. Mitolyn, a mitochondria-focused supplement targeting cellular energy and metabolic function, continues to dominate expert reviews and affiliate lists in 2026,...
-
Brain Hacks and Blood Sugar: The Quiet Growth of Biohacking in 2026
In the past 48 hours, the biohacking industry shows limited major movements, with activity centered on supplement and audio-based cognitive enhancement products amid steady consumer interest in nootropics and brain optimization. No significant market disruptions, regulatory changes, or supply…
more -
Longevity Biotech Boom: GLP-1 Drugs, Senolytics and the Future of Anti-Aging Medicine
In the past 48 hours, the biohacking industry shows steady momentum in longevity biotech, with no major disruptions but growing institutional investment and product buzz. Global R&D spending on longevity-focused biotech exceeds 40 billion dollars annually, tripling since 2020, per...
-
Mitochondrial Health Meets Wellness Culture: The Rise of Community Biohacking in 2026
In the past 48 hours, the biohacking industry shows steady momentum in mitochondrial health and experiential wellness, with no major market disruptions or regulatory shifts reported. Mitolyn, a mitochondria-focused supplement targeting cellular energy and weight management, continues gaining...
-
Biohacking Goes Mainstream: Peptides, Supply Chains, and the Future of Human Optimization
In the past 48 hours, the biohacking industry shows steady momentum toward mainstream longevity pursuits, with no major disruptions but growing supply chain concerns and consumer experimentation.[1][2] The recent Biohackers World Conference in late March 2026 in Los Angeles highlighted the…
more -
Biohacking Booms: Nootropics, Peptides, and Longevity Drive 134 Billion Dollar Industry by 2030
In the past 48 hours, the biohacking industry shows steady momentum driven by cognitive optimization and longevity trends, with no major market disruptions or regulatory shifts reported. Global market projections remain bullish, forecasting growth to 134.75 billion by 2030 and 159 billion by…
more -
Biohacking Boom: RFK Jr Pushes FDA Reform as Peptide Market Explodes to 12B
Biohacking Industry Analysis: Past 48 Hours The biohacking industry is experiencing cautious optimism driven by regulatory advocacy and growing consumer interest in peptides and nootropics.[1] RFK Jr. has intensified calls for FDA deregulation, specifically pushing to reclassify 14 restricted...
-
Biohacking Boom: RFK Jr Pushes FDA Peptide Deregulation as NAD Market Soars to 12B
In the past 48 hours, the biohacking industry displays cautious optimism fueled by regulatory advocacy and surging consumer interest in peptides and nootropics.[1] RFK Jr. has intensified calls for FDA deregulation, pushing to reclassify 14 restricted peptides banned under a 2023 Biden-era rule...
-
Peptide Policy Shifts: RFK Jr. Pushes FDA Deregulation While Biohacking Booms
In the past 48 hours, the biohacking industry shows cautious optimism amid regulatory buzz and rising consumer interest in peptides and nootropics. RFK Jr. continues advocating for easier access to 14 restricted peptides, criticizing a 2023 Biden-era FDA rule that banned compounding pharmacies…
more -
Unregulated Peptides: The Biohacking Industry's $30B Longevity Boom vs Growing Safety Risks
In the past 48 hours, the biohacking industry faces growing scrutiny over unregulated peptides, even as its longevity sector holds a robust 30 billion dollar valuation. A Telegraph report highlights influencers and sellers pushing untested get-fit-quick peptide injectables, targeting vain…
more -
Biohacking and Longevity: How Personalized Medicine is Reshaping Wellness in 2026
In the past 48 hours, the biohacking industry shows steady momentum amid growing consumer interest in longevity and personalized health, though no major market disruptions or regulatory shifts have surfaced. Regional enthusiasm in the Middle East is surging, with Dubai's MedTech World 2026 event...
-
Biohacking Market Surges 15 Percent: Wearables and At-Home Testing Lead Growth
In the past 48 hours, the biohacking industry shows steady momentum amid a broader longevity economy surge, though no major disruptions or regulatory shifts dominate headlines. The Longevity Economy and Biohacking 2.0 Market continues to drive a paradigm shift in aging approaches, with growing...
-
Biohacking 2026: Why Email Beats Apps and Dubai Leads the Wellness Revolution
In the past 48 hours, the biohacking industry shows steady momentum with no major disruptions, focusing on niche wellness expansions and long-term growth projections. Dubai has emerged as a hotspot, with new guides highlighting cold plunges, red light therapy, grounding sheets, IV drips, and...
-
Biohacking World 2026: Separating Evidence-Based Trends from Hype
In the past 48 hours, the biohacking industry shows steady momentum centered on conferences and data-driven scrutiny, with no major market disruptions, deals, or regulatory shifts reported.[1] Biohackers World 2026 kicked off March 29 at Los Angeles InterContinental Hotel, drawing visionaries to...
-
Peptide Craze 2026: Social Media Hype vs Health Expert Warnings on Unregulated Biohacks
The biohacking industry is experiencing a surge in popularity driven by social media hype around peptides, but faces growing skepticism from health experts amid regulatory voids and unproven claims[1][2][5]. In the past 48 hours, discussions highlight peptides as the hot trend, with U.S. Google...
-
Biohacking Industry 2026: Wearables, Data-Driven Wellness and Consumer Trends
Based on the available search results, I can provide limited information about the biohacking industry over the past 48 hours, as the results do not contain comprehensive recent market data, deals, partnerships, or regulatory changes specific to this timeframe. What the search results do show is...
-
Biohacking in 2026: AI Coaching, Peptides, and the Regulatory Gray Zone
In the past 48 hours as of late March 2026, the biohacking industry shows steady momentum amid growing mainstream adoption, though specific market disruptions remain limited. Longevity clinics and peptide suppliers are booming, with BPC-157 and TB-500 peptides drawing intense focus for joint...
-
From Fringe to Mainstream: The Biohacking Boom Reshaping Retail and Longevity Markets in 2024
Biohacking Industry Current State Analysis: Past 48 Hours Snapshot In the past 48 hours, the biohacking sector shows robust mainstreaming, with retailers aggressively integrating longevity-focused products amid explosive market growth. The global biohacking market, valued at 24.5 billion dollars…
more -
Biohacking Goes Mainstream: 111 Billion Dollar Market Boom and FDA Peptide Approval Signal
Current State Analysis of the Biohacking Industry: Past 48 Hours In the last 48 hours as of March 23, 2026, the biohacking industry shows accelerating mainstream adoption, with retailers aggressively integrating biohacking products amid surging consumer demand for longevity-focused wellness.[1]…
more -
Biohacking Market Boom: 18.75% Growth Through 2032, But Skepticism Rises
The biohacking industry shows steady growth momentum over the past 48 hours, with no major disruptions but continued hype around cognitive and energy supplements. The global biohacking market was valued at USD 29,526.01 million in 2025 and is projected to reach USD 98,319.59 million by 2032,...
-
Peptide Boom: FDA Loosening Rules, Market Hits $52.6B, What You Need to Know
In the past 48 hours, the biohacking industry shows momentum from regulatory shifts and product innovations, with RFK Jr. pushing to loosen FDA restrictions on nearly 20 peptides like ipamorelin, CJC-1295, BPC-157, and TB-500, potentially enabling U.S. compounding pharmacies to supply...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Biohacking News Tracker: Stay Ahead in the World of Biohacking
Welcome to "Biohacking News Tracker," your go-to podcast for the latest updates and breakthroughs in the world of biohacking. From cutting-edge technologies and genetic engineering to personalized health and wellness strategies, we cover it all. Each episode features expert interviews, in-depth analysis, and the most current news in biohacking and human optimization.
Join us as we explore the intersection of biology and technology, uncovering innovative ways to enhance human potential. Whether you're a biohacking enthusiast, a tech aficionado, or simply curious about the future of health, "Biohacking News Tracker" offers insightful and actionable information. Subscribe now and stay ahead in the rapidly evolving world of biohacking.
For more info https://www.quietperiodplease.com/
This show i
HOSTED BY
Inception Point Ai
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Biohacking News have?
Biohacking News currently has 340 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Biohacking News about?
Biohacking News Tracker: Stay Ahead in the World of Biohacking Welcome to "Biohacking News Tracker," your go-to podcast for the latest updates and breakthroughs in the world of biohacking. From cutting-edge technologies and genetic engineering to personalized health and wellness strategies, we...
How often does Biohacking News release new episodes?
Biohacking News is no longer actively publishing new episodes, but the existing catalog remains available.
Where can I listen to Biohacking News?
You can listen to Biohacking News on PodParley by clicking any episode. We provide an embedded audio player for direct listening.
Who hosts Biohacking News?
Biohacking News is created and hosted by Inception Point Ai.
URL copied to clipboard!